About Chemagis
Global Presence
News & Events
Environment
Careers at Chemagis
Contact Us
API and FDF Products
Services
Patents
Customer Support
Home Page > API and FDF Products

Chemagis’ Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) are carefully selected to provide our customers with a competitive market position by delivering a unique IP as part of a total solution. All these products comply with the exacting regulatory requirements of leading health authorities, including the FDA, MCA, TGA and HPB.

 
APITherapeutic useAvailable as FDF
Anastrozole

Non-steroidal aromatase inhibitor

Cetirizine Dihydrochloride

Non-sedative antihistamine

Cilostazol

Antithrombotic

Donepezil Hydrochloride

Antialzheimer, Cognition enhancer

Exemestane

Steroidal aromatase inhibitor

Fenofibrate

Antihyperlipoproteinemic

Flumazenil

Benzodiazepine antagonist

Fluticasone Propionate

Antiinflammatory, Antiallergic agent

Gemcitabine Hydrochloride

Antimetabolite, Antineoplastic

Granisetron Hydrochloride

Antinauseant, Antiemetic

Imiquimod

Immune response modifier

Lamotrigine

Antiepileptic

Letrozole

Non-steroidal aromatase inhibitor

Levocetirizine Dihydrochloride

Non-sedative antihistamine

Midazolam Base

Central nervous system depressant, Anesthetic, Sleeping aid

Midazolam HCl

 Central nervous system depressant, Anesthetic, Sleeping aid

Midazolam Maleate

Central nervous system depressant, Anesthetic, Sleeping aid

Modafinil

Antinarcoleptic

Mometasone Furoate

Antiinflammatory

Montelukast Sodium

Prophylaxis of asthma

Moxonidine

Antihypertensive

Pentoxifylline

Vasodilator

Pramipexole Dihydrochloride

Antiparkinsonian

R-Modafinil

Antinarcoleptic

Rocuronium Bromide

Neuromuscular blocker

Temozolomide

Antineoplastic, alkylating agent

Terbinafine Hydrochloride

Antidermatophyte (fungal infections of the nails)

Tramadol Hydrochloride

Analgesic

Zonisamide

Antiepileptic


Under DevelopmentTherapeutic useavailable as FDF
Atovaquone

Antiprotozoal

Azacitidine

Antineoplastic agent

Cisatracurium Besylate

Intermediate duration neuromuscular blocking agent

Imatinib Mesylate

Tyrosine kinase inhibitor (treatment of CML)

Palonosetron

Antiemetic

Rotigotine

Treatment of early and advanced stage of Parkinson's disease

Tioconazole

Anti vaginal candida infections


© Copyright Chemagis 2008